Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK2 | O00142 | 8/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
| ▸ | DUT | P33316 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | VDR | P11473 | 1/20 | 0.38 |
| ▸ | CYP24A1 | Q07973 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | TK1 | P04183 | 1/20 | 0.38 |
| ▸ | STAT3 | P40763 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9524449 | 1.00 | TK2 (0.47) | TK2ALDH1A1KIF11DUTCA12 | |
| SCHEMBL27443036 | 1.00 | TK2 (0.47) | TK2ALDH1A1KIF11DUTCA12 | |
| SCHEMBL27443043 | 1.00 | TK2 (0.47) | TK2ALDH1A1KIF11DUTCA12 | |
| SCHEMBL9523426 | 1.00 | TK2 (0.47) | TK2ALDH1A1KIF11DUTCA12 | |
| SCHEMBL4303777 | 0.94 | TK1 (0.43) | TK2ALDH1A1KIF11DUTCA12 | |
| SCHEMBL4013278 | 0.94 | TK2 (0.42) | TK2ALDH1A1KIF11DUTCA12 | |
| SCHEMBL2381255 | 0.92 | SLC6A11 (0.43) | TK2ALDH1A1KIF11CA12CA1 | |
| SCHEMBL6046754 | 0.92 | SLC6A11 (0.43) | TK2ALDH1A1KIF11CA12CA1 | |
| SCHEMBL31516447 | 0.88 | TK1 (0.46) | TK2ALDH1A1KIF11VDRCYP24A1 | |
| SCHEMBL26103993 | 0.86 | TK2 (0.47) | TK2ALDH1A1KIF11VDRCYP24A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11945838-B2 | Method for synthesis of protein amphiphiles | INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH (IN) | 2024-04-02 | — | — | US | disclosed |
| US-11680137-B2 | Method for purifying trityl group-containing monodispersed polyethylene glycol | NOF CORPORATION (JP) | 2023-06-20 | — | — | US | disclosed |
| US-11173212-B2 | Supramolecular protein assemblies with advanced functions and synthesis thereof | INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH (IN) | 2021-11-16 | — | — | US | disclosed |
| US-20200199175-A1 | METHOD FOR SYNTHESIS OF PROTEIN AMPHIPHILES | INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH | 2020-06-25 | — | — | US | disclosed |
| US-20190134212-A1 | SUPRAMOLECULAR PROTEIN ASSEMBLIES WITH ADVANCED FUNCTIONS AND SYNTHESIS THEREOF | INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH (IN) | 2019-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200199175-A1 | METHOD FOR SYNTHESIS OF PROTEIN AMPHIPHILES | PTMS, VAC14, PDIA6 | TK2 3618/4885ALDH1A1 4784/4885KIF11 3691/4885 |
| US-20190134212-A1 | SUPRAMOLECULAR PROTEIN ASSEMBLIES WITH ADVANCED FUNCTIONS AND SYNTHESIS THEREOF | APC, CHLSN, MAX | TK2 4417/4885ALDH1A1 4627/4885KIF11 2577/4885 |
| US-11945838-B2 | Method for synthesis of protein amphiphiles | PTMS, VAC14, PDIA6 | TK2 3618/4885ALDH1A1 4784/4885KIF11 3691/4885 |
| US-11173212-B2 | Supramolecular protein assemblies with advanced functions and synthesis thereof | APC, CHLSN, MAX | TK2 4417/4885ALDH1A1 4627/4885KIF11 2577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.